Holdings of EQ/T.Rowe Price Health Sciences Portfolio
EQ Advisors Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 176.6M $ including 175.7M $ in equities, 99.5 %
- Positions
- 166 in 16 countries
- Top ten
- 48.5 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | ALUMIS INC | 9,325 | 262.4K $ | 0.15 % |
| 102 | Apogee Therapeutics Inc | 1,936 | 257K $ | 0.15 % |
| 103 | Stoke Therapeutics Inc | 7,792 | 255K $ | 0.14 % |
| 104 | Veeva Systems Inc | 1,400 | 248.5K $ | 0.14 % |
| 105 | COGENT BIOSCIENCES INC | 6,212 | 240.4K $ | 0.14 % |
| 106 | Biohaven Ltd | 15,998 | 238.1K $ | 0.13 % |
| 107 | Generate Biomedicines Inc | 13,453 | 227K $ | 0.13 % |
| 108 | ABIVAX SA | 1,683 | 224.3K $ | 0.13 % |
| 109 | Encompass Health Corp | 2,209 | 223.3K $ | 0.13 % |
| 110 | OCULAR THERAPEUTIX INC | 22,400 | 220K $ | 0.12 % |
| 111 | BELITE BIO INC | 1,400 | 215.6K $ | 0.12 % |
| 112 | Arrowhead Pharmaceuticals Inc | 2,561 | 208.7K $ | 0.12 % |
| 113 | Incyte Corp | 1,807 | 204.8K $ | 0.12 % |
| 114 | Immix Biopharma Inc | 19,704 | 203.1K $ | 0.12 % |
| 115 | Shattuck Labs Inc | 28,510 | 197.9K $ | 0.11 % |
| 116 | Cullinan Therapeutics Inc | 10,800 | 196.7K $ | 0.11 % |
| 117 | Sionna Therapeutics Inc | 4,455 | 196K $ | 0.11 % |
| 118 | Parabilis Medicines Inc | 7,141 | 195.4K $ | 0.11 % |
| 119 | AVALYN PHARMA INC | 5,781 | 190.3K $ | 0.11 % |
| 120 | BioNTech SE | 2,000 | 186.1K $ | 0.11 % |
| 121 | Corvus Pharmaceuticals Inc | 12,357 | 184.6K $ | 0.10 % |
| 122 | IQVIA Holdings Inc | 902 | 174.3K $ | 0.10 % |
| 123 | Quest Diagnostics Inc | 800 | 169.6K $ | 0.10 % |
| 124 | TARSUS PHARMACEUTICALS INC | 2,660 | 167.4K $ | 0.09 % |
| 125 | Pharvaris NV | 4,824 | 166.8K $ | 0.09 % |
| 126 | TYRA BIOSCIENCES INC | 5,200 | 166.1K $ | 0.09 % |
| 127 | AKTIS ONCOLOGY INC | 4,864 | 156.8K $ | 0.09 % |
| 128 | Disc Medicine Inc | 2,096 | 153.3K $ | 0.09 % |
| 129 | Olema Pharmaceuticals Inc | 11,900 | 148.9K $ | 0.08 % |
| 130 | Denali Therapeutics Inc | 5,543 | 142.6K $ | 0.08 % |
| 131 | Atrium Therapeutics Inc | 10,400 | 139.9K $ | 0.08 % |
| 132 | AVALO THERAPEUTICS INC | 7,332 | 135.5K $ | 0.08 % |
| 133 | Nanobiotix SA | 3,569 | 131K $ | 0.07 % |
| 134 | Tenax Therapeutics Inc | 8,857 | 128.9K $ | 0.07 % |
| 135 | Allogene Therapeutics Inc | 59,892 | 124.6K $ | 0.07 % |
| 136 | HEMAB THERAPEUTICS HOLDINGS INC | 3,022 | 111K $ | 0.06 % |
| 137 | WAVE LIFE SCIENCES LTD | 18,793 | 109.2K $ | 0.06 % |
| 138 | Alto Neuroscience Inc | 4,100 | 108.2K $ | 0.06 % |
| 139 | Kyverna Therapeutics Inc | 11,854 | 105.6K $ | 0.06 % |
| 140 | Odyssey Therapeutics Inc | 5,571 | 104.2K $ | 0.06 % |
| 141 | Adaptive Biotechnologies Corp | 4,598 | 98.6K $ | 0.06 % |
| 142 | SpyGlass Pharma Inc | 4,214 | 93.8K $ | 0.05 % |
| 143 | IMMATICS NV | 8,500 | 86.1K $ | 0.05 % |
| 144 | Inspire Medical Systems Inc | 1,900 | 84.8K $ | 0.05 % |
| 145 | CABALETTA BIO INC | 26,242 | 81.6K $ | 0.05 % |
| 146 | Celcuity Inc | 770 | 80.6K $ | 0.05 % |
| 147 | CRESCENT BIOPHARMA INC | 4,414 | 79.5K $ | 0.05 % |
| 148 | Evommune Inc | 5,933 | 78.8K $ | 0.04 % |
| 149 | Iovance Biotherapeutics Inc | 18,427 | 76.7K $ | 0.04 % |
| 150 | Procept Biorobotics Corp | 3,327 | 75.1K $ | 0.04 % |
| 151 | Agios Pharmaceuticals Inc | 1,992 | 73.9K $ | 0.04 % |
| 152 | Xencor Inc | 4,411 | 71K $ | 0.04 % |
| 153 | Eikon Therapeutics Inc | 5,071 | 66.2K $ | 0.04 % |
| 154 | Xenon Pharmaceuticals Inc | 900 | 54.3K $ | 0.03 % |
| 155 | SENSORION SA | 190,926 | 51.6K $ | 0.03 % |
| 156 | BioMarin Pharmaceutical Inc | 900 | 51.5K $ | 0.03 % |
| 157 | Entrada Therapeutics Inc | 6,365 | 46.8K $ | 0.03 % |
| 158 | GE HealthCare Technologies Inc | 700 | 44.8K $ | 0.03 % |
| 159 | Immuneering Corp | 8,767 | 43.7K $ | 0.02 % |
| 160 | BICYCLE THERAPEUTICS PLC | 9,600 | 40.7K $ | 0.02 % |
| 161 | DYNE THERAPEUTICS INC | 1,800 | 40K $ | 0.02 % |
| 162 | BridgeBio Oncology Therapeutics Inc | 4,884 | 37.2K $ | 0.02 % |
| 163 | CARIS LIFE SCIENCES INC | 1,579 | 28.1K $ | 0.02 % |
| 164 | Aura Biosciences Inc | 3,602 | 25.6K $ | 0.01 % |
| 165 | MAPLIGHT THERAPEUTICS INC | 633 | 22.7K $ | 0.01 % |
| 166 | Tectonic Therapeutic Inc | 536 | 18.4K $ | 0.01 % |
Sector breakdown
- Health care 71.0 %
- Technology 0.1 %
- Unattributed 28.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.8 %
- JPY 0.5 %
- HKD 0.4 %
- CHF 0.2 %
- EUR 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.4 %
- Netherlands 1.1 %
- Bermuda 0.8 %
- Denmark 0.7 %
- United Kingdom 0.5 %
- Japan 0.5 %
- Ireland 0.4 %
- Hong Kong SAR China 0.4 %
- Cayman Islands 0.3 %
- Israel 0.2 %
- France 0.2 %
- Switzerland 0.2 %
- Other countries 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 142 | 165.8M $ | 94.37 % |
| 2 | Netherlands | 4 | 1.9M $ | 1.06 % |
| 3 | Bermuda | 1 | 1.3M $ | 0.76 % |
| 4 | Denmark | 2 | 1.3M $ | 0.71 % |
| 5 | United Kingdom | 2 | 905K $ | 0.52 % |
| 6 | Japan | 1 | 898.2K $ | 0.51 % |
| 7 | Ireland | 2 | 744K $ | 0.42 % |
| 8 | Hong Kong SAR China | 1 | 699.3K $ | 0.40 % |
| 9 | Cayman Islands | 2 | 488.4K $ | 0.28 % |
| 10 | Israel | 1 | 423.5K $ | 0.24 % |
| 11 | France | 3 | 406.9K $ | 0.23 % |
| 12 | Switzerland | 1 | 288.3K $ | 0.16 % |
Cite this page
Titelia. "Holdings of EQ/T.Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000062644